334 related articles for article (PubMed ID: 11601330)
1. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of overproduction of plasma prostacyclin in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Jiao Z; Chen Z; Kuang Y
Chin Med J (Engl); 1998 Dec; 111(12):1064-7. PubMed ID: 11263364
[TBL] [Abstract][Full Text] [Related]
3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
4. [The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Wu ZY; Chen XS; Cao H
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):537-40. PubMed ID: 12921664
[TBL] [Abstract][Full Text] [Related]
5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
7. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats.
Wu ZY; Chen XS; Qiu JF; Cao H
World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
9. The role of vasoactive substances in hyperhemodynamics after orthotopic liver transplantation in cirrhotic rats.
Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
Chin Med J (Engl); 2003 Mar; 116(3):405-9. PubMed ID: 12781047
[TBL] [Abstract][Full Text] [Related]
10. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
Chin Med J (Engl); 2000 Dec; 113(12):1108-11. PubMed ID: 11776147
[TBL] [Abstract][Full Text] [Related]
11. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z
Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021
[TBL] [Abstract][Full Text] [Related]
12. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
15. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
Albornoz L; Bandi JC; de las Heras M; Mastai R
Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
[TBL] [Abstract][Full Text] [Related]
16. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
Sitzmann JV; Li SS; Adkinson NF
Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
18. [Expression of ET-1 mRNA in the lung of hepatopulmonary syndrome rats].
Ni X; Wu Z; Chen Z; Kuang Y
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):142-5. PubMed ID: 11955402
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
[TBL] [Abstract][Full Text] [Related]
20. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
